1601 TRAPELO ROAD, WALTHAM, MA
Market cap: $196.4M (2/08/2026)
Price: $1.48
Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
Announces Proposed Public Offering of Common Stock
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Life Can Only Be Understood Backwards; But It Must Be Lived Forwards… Kierkegaard 1
U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Appoints Paul B. Bolno, M.D. to Its Board of Directors
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Additional Proxy Soliciting Materials
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Free Writing Prospectus